Natriuretic peptides exert cardioprotective effects through antihypertrophic and antifibrotic mechanisms, suggesting potential therapeutic utility in heart failure.
No takes yet. Share an insight, caveat, or question.
Supports ANP/BNP pathway targeting in HF; leaves open clinical translation from preclinical models.
Nishikimi et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: